Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2024-05-28 14:17 Tx date 2024-05-27 |
$INM
InMed Pharmaceuticals Inc. |
Hsu, Eric Chih-Hsien
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-195,586.875
-545 vol $358.88 each |
52,000 | |
Filed 2024-03-05 12:51 Tx date 2024-03-04 |
$INM
InMed Pharmaceuticals Inc. |
Hsu, Eric Chih-Hsien
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-152,955
-309 vol $495.00 each |
52,545 | |
Filed 2023-12-26 11:00 Tx date 2023-12-23 |
$INM
InMed Pharmaceuticals Inc. |
Hsu, Eric Chih-Hsien
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$16,650
+45,000 vol $0.37 each |
52,854 | |
Filed 2023-08-31 13:08 Tx date 2023-08-31 |
$INM
InMed Pharmaceuticals Inc. |
Hsu, Eric Chih-Hsien
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-221,215.50
-327 vol $676.50 each |
7,854 | |
Filed 2023-05-16 12:14 Tx date 2023-05-16 |
$INM
InMed Pharmaceuticals Inc. |
Hsu, Eric Chih-Hsien
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-127,908
-152 vol $841.50 each |
8,181 | |
Filed 2023-03-08 13:07 Tx date 2023-03-08 |
$INM
InMed Pharmaceuticals Inc. |
Hsu, Eric Chih-Hsien
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-696,918.75
-545 vol $1,278 each |
8,333 | |
Filed 2022-12-19 13:47 Tx date 2022-12-16 |
$INM
InMed Pharmaceuticals Inc. |
Hsu, Eric Chih-Hsien
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$7,476
+4,200 vol $1.78 each |
8,878 | |
Filed 2022-11-17 15:15 Tx date 2022-11-14 |
$INM
InMed Pharmaceuticals Inc. |
Hsu, Eric Chih-Hsien
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$11,676
+4,200 vol $2.78 each |
||
Filed 2022-11-15 18:04 Tx date 2022-11-14 |
$INM
InMed Pharmaceuticals Inc. |
Hsu, Eric Chih-Hsien
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$11,676
+4,200 vol $2.78 each |
||
Filed 2022-11-15 18:04 Tx date 2022-11-14 |
$INM
InMed Pharmaceuticals Inc. |
Hsu, Eric Chih-Hsien
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$11,676
+4,200 vol $2.78 each |
8,878 | |
Filed 2022-10-12 18:10 Tx date 2022-09-07 |
$INM
InMed Pharmaceuticals Inc. |
Hsu, Eric Chih-Hsien
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-1,221 vol |
51 | |
Filed 2022-10-12 18:10 Tx date 2022-09-07 |
$INM
InMed Pharmaceuticals Inc. |
Hsu, Eric Chih-Hsien
5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-112,291 vol |
4,678 | |
Filed 2021-10-19 18:52 Tx date 2021-10-18 |
$INM
InMed Pharmaceuticals Inc. |
Hsu, Eric Chih-Hsien
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+35,000 vol |
116,969 | |
Filed 2020-12-17 14:52 Tx date 2020-06-30 |
$IN
InMed Pharmaceuticals Inc. |
Hsu, Eric Chih-Hsien
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-40,728 vol |
1,272 | |
Filed 2020-12-17 14:32 Tx date 2020-12-16 |
$IN
InMed Pharmaceuticals Inc. |
Hsu, Eric Chih-Hsien
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+35,000 vol |
81,969 | |
Filed 2020-12-17 14:26 Tx date 2020-06-30 |
$IN
InMed Pharmaceuticals Inc. |
Hsu, Eric Chih-Hsien
5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-1,503,031 vol |
46,969 | |
Filed 2019-07-10 14:27 Tx date 2019-07-10 |
$IN
InMed Pharmaceuticals Inc. |
Hsu, Eric Chih-Hsien
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$14,742
+42,000 vol $0.351 each |
42,000 | |
Filed 2019-07-10 14:21 Tx date 2018-03-12 |
$IN
InMed Pharmaceuticals Inc. |
Hsu, Eric Chih-Hsien
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-05-28 18:18 Tx date 2019-05-27 |
$IN
InMed Pharmaceuticals Inc. |
Hsu, Eric Chih-Hsien
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$195,750
+450,000 vol $0.435 each |
1,550,000 | |
Filed 2019-03-07 Tx date 2019-03-04 |
$IN
InMed Pharmaceuticals Inc. |
Hsu, Eric Chih-Hsien
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$153,000
+255,000 vol $0.60 each |
||
Filed 2019-03-07 Tx date 2019-03-04 |
$IN
InMed Pharmaceuticals Inc. |
Hsu, Eric Chih-Hsien
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$153,000
+255,000 vol $0.60 each |
1,100,000 | |
Filed 2018-09-04 Tx date 2018-08-31 |
$IN
InMed Pharmaceuticals Inc. |
Hsu, Eric Chih-Hsien
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$221,400
+270,000 vol $0.82 each |
845,000 | |
Filed 2018-05-17 Tx date 2018-05-16 |
$IN
InMed Pharmaceuticals Inc. |
Hsu, Eric Chih-Hsien
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$127,500
+125,000 vol $1.02 each |
575,000 | |
Filed 2018-03-14 Tx date 2018-03-12 |
$IN
InMed Pharmaceuticals Inc. |
Hsu, Eric Chih-Hsien Hsu
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
450,000 |